William Mack & Associates
XYL icon

William Mack & Associates’s Xylem XYL Stock Holding History

William Mack & Associates’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25K Buy
+247
New +$28.3K 0.01% 309

Other funds holding XYL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $13B AUM 14.15% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

William Mack & Associates's XYL Position: Q3 2026 in Review

William Mack & Associates opened a new position in Xylem (XYL) in Q3 2026: 247 shares worth $25K. The stake represents 0.01% of the portfolio and ranks #309 among its holdings.

906 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • William Mack & Associates held 247 shares of Xylem worth $25K as of Q3 2026.
  • Xylem was a new William Mack & Associates position in Q3 2026.
  • Xylem made up 0.01% of William Mack & Associates's portfolio in Q3 2026, its #309 holding.
  • 906 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.